Tumor microenvironment-responsive polymeric nanoparticles for enhanced immunotherapy
Cancer remains a major global health threat with the World Health Organization reporting 20 million new cases and 9.7 million deaths worldwide in 2022 that is projected to surge by 77% to 35% million annual cases by 2050[1][1]. In recent years immunotherapy has rapidly advanced, offering new hope
Authors
- Shaobing Zhou (ORCID: https://orcid.org/0000-0002-6155-4010)
- Yongxin Zhang (ORCID: https://orcid.org/0000-0002-9243-2673)
- Jingya Zhao (ORCID: https://orcid.org/0000-0001-6291-0964)
Institutions
- Southwest Jiaotong University (CN)
Publication Details
- Journal
- Cancer Biology and Medicine
- Published
- 2025-12-03
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2025.0517
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67
Funders
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities